Eurofarma Laboratories S.A.
The investigational product constitutes a medical device that is freely accessible to consumers and, as such, must be safe under real or reasonably foreseeable conditions of use and its safety must be tested before being placed on the market. Therefore, this study was designed to evaluate the biocompatibility of the experimental product, as provided for in legislation.
Skin Care
Liquid bandage
Saline Solution
NA
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 88 participants |
Masking : | SINGLE |
Primary Purpose : | SCREENING |
Official Title : | Assessment of the Primary, Accumulated Irritability and Skin Sensitization Potential of an Elastic Collodion-based Liquid Bandage Under Controlled and Maximized Conditions (RIPT) |
Actual Study Start Date : | 2025-01-31 |
Estimated Primary Completion Date : | 2025-02-28 |
Estimated Study Completion Date : | 2025-02-28 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years to 70 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Allergic
Campinas, São Paulo, Brazil, 13084-791
Not yet recruiting
Eurofarma Laboratorios S.A
São Paulo, Brazil, 06696-000